@article {46405,
	title = {IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.},
	journal = {The Journal of Clinical Investigation},
	volume = {117},
	year = {2007},
	month = {2007 Jun},
	pages = {1538-49},
	abstract = {<p>ST2 is an IL-1 receptor family member with transmembrane (ST2L) and soluble (sST2) isoforms. sST2 is a mechanically induced cardiomyocyte protein, and serum sST2 levels predict outcome in patients with acute myocardial infarction or chronic heart failure. Recently, IL-33 was identified as a functional ligand of ST2L, allowing exploration of the role of ST2 in myocardium. We found that IL-33 was a biomechanically induced protein predominantly synthesized by cardiac fibroblasts. IL-33 markedly antagonized angiotensin II- and phenylephrine-induced cardiomyocyte hypertrophy. Although IL-33 activated NF-kappaB, it inhibited angiotensin II- and phenylephrine-induced phosphorylation of inhibitor of NF-kappa B alpha (I kappa B alpha) and NF-kappaB nuclear binding activity. sST2 blocked antihypertrophic effects of IL-33, indicating that sST2 functions in myocardium as a soluble decoy receptor. Following pressure overload by transverse aortic constriction (TAC), ST2(-/-) mice had more left ventricular hypertrophy, more chamber dilation, reduced fractional shortening, more fibrosis, and impaired survival compared with WT littermates. Furthermore, recombinant IL-33 treatment reduced hypertrophy and fibrosis and improved survival after TAC in WT mice, but not in ST2(-/-) littermates. Thus, IL-33/ST2 signaling is a mechanically activated, cardioprotective fibroblast-cardiomyocyte paracrine system, which we believe to be novel. IL-33 may have therapeutic potential for beneficially regulating the myocardial response to overload.</p>
},
	keywords = {Animals, Biomechanical Phenomena, Cardiotonic Agents, Cells, Cultured, Fibroblasts, Humans, Interleukins, Membrane Proteins, Mice, Mice, Inbred C57BL, Mice, Knockout, Myocytes, Cardiac, NF-kappa B, Rats, Receptors, Cell Surface, Receptors, Interleukin, Recombinant Proteins, Signal Transduction},
	issn = {0021-9738},
	doi = {10.1172/JCI30634},
	author = {Sanada, Shoji and Hakuno, Daihiko and Higgins, Luke J and Schreiter, Eric R and McKenzie, Andrew N J and Lee, Richard T}
}
